“…A multiplex tandem mass spectrometry (MS/MS) assay for five LSDs (KD, Gaucher, Pompe, Niemann-Pick, and Fabry diseases) was developed 13 and optimized for use on dried blood spots. 15,18,19 There are challenges to adding LSDs to NBS panels, including the need for expensive instrumentation and adequate quality control materials (especially dried blood spots from infants with KD), 14,20 diagnostic laboratories for confirmatory testing with short turnaround times, infrastructure for rapid referral and urgent transplantation in newborns with EIKD, protocols for follow-up, and clinicians experienced in interpreting and relaying the full spectrum of NBS results, including variability in enzyme activity and identification of sequence variants of unknown significance or variable expressivity. 21 Early studies showed that a small cohort of infantile KD patients who received umbilical cord blood transplantation from unrelated donors prior to symptom onset had preserved neurological function.…”